CDNA Caredx Inc

Price (delayed)

$73.72

Market cap

$3.87B

P/E Ratio

29.61

Dividend/share

N/A

EPS

$2.49

Enterprise value

$3.64B

?
Relative Growth: Rel. Growth: 83
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 46
Relative Profitability: Rel. Profitability: 97

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and ...

Highlights
Caredx's EPS has soared by 84% YoY and by 16% from the previous quarter
Caredx's net income has soared by 83% YoY and by 16% from the previous quarter
The debt has surged by 54% since the previous quarter but it has declined by 4.2% year-on-year
The company's quick ratio has shrunk by 50% QoQ and by 12% YoY

Key stats

What are the main financial stats of CDNA

CDNA stock price

How has the Caredx stock price performed over time
Intraday
-5.34%
1 week
-12.67%
1 month
15.19%
1 year
362.63%
YTD
291.3%
QTD
13.42%

Financial performance

How have Caredx's revenue and profit performed over time
Revenue
$497.4M
Gross profit
$353M
Operating income
$116.49M
Net income
$128.63M
Gross margin
71%
Net margin
25.9%
The operating income has surged by 95% year-on-year and by 8% since the previous quarter
Caredx's net income has soared by 83% YoY and by 16% from the previous quarter
CDNA's gross profit is up by 46% year-on-year and by 9% since the previous quarter
Caredx's operating margin has increased by 40% YoY

Price vs fundamentals

How does CDNA's price correlate with its fundamentals

Growth

What is Caredx's growth rate over time

Valuation

What is Caredx stock price valuation
P/E
29.61
P/B
8.16
P/S
7.72
EV/EBIT
31.3
EV/EBITDA
26
EV/Sales
7.32
Caredx's EPS has soared by 84% YoY and by 16% from the previous quarter
The stock's price to book (P/B) is 172% more than its 5-year quarterly average of 3.0 and 94% more than its last 4 quarters average of 4.2
The equity has soared by 50% YoY and by 10% from the previous quarter
The price to sales (P/S) is 134% more than the 5-year quarterly average of 3.3 and 109% more than the last 4 quarters average of 3.7
The revenue has increased by 39% YoY and by 9% QoQ

Efficiency

How efficient is Caredx business performance
CDNA's return on assets has surged by 69% year-on-year and by 3.6% since the previous quarter
The ROE has soared by 69% YoY and by 4% from the previous quarter
The ROIC has soared by 53% QoQ
Caredx's ROS has increased by 38% YoY

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did Caredx financials performed over time
Caredx's total liabilities has soared by 62% from the previous quarter and by 44% YoY
The company's quick ratio has shrunk by 50% QoQ and by 12% YoY
The debt is 96% smaller than the equity
The debt has surged by 54% since the previous quarter but it has declined by 4.2% year-on-year
The equity has soared by 50% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.